Each filer's latest filing for M8694L137 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Moshe Arkin
13D/A
|
56.6% |
4/15/2026
Event 3/25/2026
|
||
| Moshe Arkin | 56.6% | |||
| M. Arkin Dermatology Ltd. | 52.4% | |||
|
Opaleye Management Inc.
13G/A
|
16.5% |
11/6/2026
Event 9/30/2026
|
||
| Opaleye Management Inc. | 16.5% | |||
| Opaleye, L.P. | 16.0% | |||
| James Silverman | 16.5% | |||
|
Great Point Partners, LLC
13G
|
8.5% |
3/31/2026
Event 3/24/2026
|
||
| Great Point Partners, LLC | 8.5% | |||
| Dr. Jeffrey R. Jay, M.D. | 8.5% | |||
| Ms. Lillian Nordahl | 8.5% | |||
|
Trails Edge Capital Partners, LP
13G
|
5.1% |
10/27/2026
Event 10/20/2026
|
||
| Trails Edge Capital Partners, LP | 5.1% | |||
| Trails Edge Biotechnology Master Fund, LP | 5.1% | |||
| Ortav Yehudai | 5.1% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
| Phoenix Financial Ltd. 13G/A | 4.99% |
6/9/2026
Event 6/2/2026
|
||